MARKET

CAPR

CAPR

Capricor Therapeutics Inc
NASDAQ
3.420
-2.395
-41.19%
After Hours: 3.440 +0.02 +0.58% 17:54 09/29 EDT
OPEN
3.850
PREV CLOSE
5.82
HIGH
3.893
LOW
3.305
VOLUME
2.68M
TURNOVER
0
52 WEEK HIGH
8.22
52 WEEK LOW
3.300
MARKET CAP
88.16M
P/E (TTM)
-2.9331
1D
5D
1M
3M
1Y
5Y
Health Care Sector Update for 09/29/2023: CAPR, SYRA, GPCR, RSLS
NASDAQ · 3h ago
US Stocks Turn Lower; Dow Tumbles Over 200 Points
Benzinga · 4h ago
Why SeaStar Medical Holding Shares Are Trading Higher By Around 35%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Benzinga · 5h ago
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga · 5h ago
Crude Oil Down 1% Following PCE Data; Blue Apron Shares Surge
Benzinga · 7h ago
Nasdaq Gains Over 1%; Nike Posts Upbeat Earnings
Benzinga · 9h ago
Capricor says FDA aligns with path to market lead asset
Seeking Alpha · 9h ago
Capricor Therapeutics Inc: Current report
Press release · 10h ago
More
About CAPR
Capricor Therapeutics, Inc. is a biotechnology company. The Company is focused on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of muscular and other select diseases. The Company’s lead candidate, CAP-1002, is an allogeneic cardiac-derived cell therapy that is in late-stage clinical development for treating Duchenne muscular dystrophy (DMD). CAP-1002 is designed to slow disease progression in DMD through the immunomodulatory, anti-inflammatory, and anti-fibrotic actions of cardiosphere-derived cells (CDCs), which are mediated by secreted exosomes laden with bioactive cargo. CAP-2003 is the name of its exosomes product candidate, which is derived from its CDCs. It is also developing its exosome technology as a therapeutic platform. The Company’s focus is on developing exosomes capable of delivering nucleic acids, including messenger RNA (mRNA), as well as proteins to treat or prevent a variety of diseases.

Webull offers kinds of Capricor Therapeutics Inc stock information, including NASDAQ:CAPR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CAPR stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading CAPR stock methods without spending real money on the virtual paper trading platform.